Development asset linked to Oruka Therapeutics in public FDA and regional records.
pharma · Plaque Psoriasis · Moderate-to-Severe Plaque Psoriasis · ORKA
Oruka Therapeutics
Oruka Therapeutics drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Waltham, USA HQ
78 Employees
Public company Type
ORKA · NYSE Ticker
Company details
- Status
- Public
- HQ
- Waltham, USA
- Employees
- 78
- Programs
- 6
- Drugs
- 3
- Patents
- 0
Oruka Therapeutics pipeline
Portfolio lens on 3 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Oruka Therapeutics drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Oruka Therapeutics in public FDA and regional records.
-
Development asset linked to Oruka Therapeutics in public FDA and regional records.